NEOG
NEOGEN CORP
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$11.63
−1.52%Forward multiples
Based on analyst estimates
- P/E forward
- 35.24x
- P/E 2026E
- 36.37x
- P/E 2027E
- 29.16x
- P/E 2028E
- 22.62x
- P/S forward
- 2.87x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.22x
- Price / sales
- 2.87x
- Price / cash flow
- 29.78x
Enterprise value
- Enterprise value
- $3.1B
- EV / sales
- 3.55x
- EV / EBITDA
- 29.88x
- EV / EBIT
- -425.80x
- Market cap
- $2.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Aug 1, 2026